SYNCOM

Syncom Healthcare Limited has informed the Exchange about

Syncom Healthcare Limited has informed the Exchange regarding Resignation of Mrs Charu Srivastava as Company Secretary & Compliance Officer of the company w.e.f. April 01, 2019.

Syncom Healthcare Limited has informed the Exchange regarding Cessation of Mr Bhismapal Singh Yadav as Other-Director and Whole Time Director of the company w.e.f. March 04, 2019.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on February 14, 2019.

SYNCOM: The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 31-Jan-2019, regarding Appointment of Mr Manoj Negi as Executive Director-Technical of the company w.e.f. January 31, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is attached.

Syncom Healthcare Limited has informed the Exchange regarding 'Advertisement for the Intimation of Board Meeting in the Newspaper- Financial Express and Nav Shakti.'.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 31-Jan-2019, regarding Appointment of Mr Manoj Negi as Executive Director-Technical of the company w.e.f. January 31, 2019.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange regarding Appointment of Mr Manoj Negi as Executive Director-Technical of the company w.e.f. January 31, 2019.

Syncom Healthcare Limited has informed the Exchange that Bank of India has initiated insolvency resolution process under 7 of the Insolvency and Bankruptcy code, 2016 read with rule 4 of the Insolvency and Bankruptcy (Appilcation to adjudicating authority), Rules, 2016.��

Syncom Healthcare Limited has informed the Exchange regarding 'Intimation to stock Exchange under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Syncom Healthcare Limited has informed the Exchange regarding 'Intimation to stock Exchange under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2018.

Syncom Healthcare Limited has informed the Exchange regarding 'Advertisement for the Intimation of Board Meeting in the Newspaper- Financial Express and Nav Shakti.'.

Syncom Healthcare Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 29, 2018

Syncom Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2018. Further, the company has informed the Exchange regarding voting results.

Syncom Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018

The Exchange had sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. No Segment Reporting. The response of the Company is enclosed.

The Exchange has sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange regarding 'website address of the company has been changed from www.syncomhealthcare.com to www.syncom.in. '.

Syncom Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 22, 2018 to September 28, 2018 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 29, 2018.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2018.

Syncom Healthcare Limited has informed the Exchange regarding 'Advertisement for the Intimation of Board Meeting in the Newspaper- Financial Express and Nav Shakti.'.

Syncom Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Syncom Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.Intimation regarding withdrawal of resignation of Dr. Bhishampal Singh Yadav (DIN 07017046)

The Exchange had sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Consolidated Reconciliation of profit and loss not submitted -2. Consolidated Reconciliation of Equity not submitted The response of the Company is enclosed.

The Exchange has sought clarification from Syncom Healthcare Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Consolidated Reconciliation of profit and loss not submitted -2. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Syncom Healthcare Limited has informed the Exchange regarding Board meeting held on May 29, 2018.

Syncom Healthcare Limited has informed the Exchange regarding 'Material events under regulation 30 of the listing regulations '.

Syncom Healthcare Limited has informed the Exchange regarding Resignation of Mr Dr. Bhishampal Singh Yadav as Additional Director of the company w.e.f. April 26, 2018. After serving a month's notice, his last working day will be May 26, 2018.

Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.　

Uma Bagaria has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 16-Jan-2018, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is attached.

Syncom Healthcare Limited has informed the Exchange regarding 'Newspaper publication '.

SYNCOM:The Exchange has sought clarification from Syncom Healthcare Limited with respect to announcement dated 16-Jan-2018, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.

Syncom Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on January 16, 2018.

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

Syncom Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Syncom Healthcare Limited has informed the Exchange regarding Appointment of Mr Amit Satardekar as Chief Financial Officer of the company w.e.f. December 18, 2017.

Syncom Healthcare Limited has informed the Exchange regarding 'Dislosure under Regulation 30 of SEBI Listing Obligation and Disclosure Regulation,2015.'.

Syncom Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2017.This is to inform you that the Board of Directors at its meeting held today i.e. 14th November 2017 on Tuesday at 07:00 P.M. at the registered office of the Company and concluded at 10:15 P.M. considered, approved and adopted unaudited standalone financial results of the Company for the financial quarter and half year ended on 30th September , 2017.A copy of the statement of the unaudited standalone financial results alongwith the Independent Limited Review Report in this regard ar

Syncom Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

Syncom Healthcare Limited has informed the Exchange regarding ''the Bank of India has taken symbolic possession of the manufacturing facility situated at Dehradun. The company has submitted a proposal for limits availed to be restructured and the outcome of the same shall be communicated at the appropriate time."

Syncom Healthcare Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 29, 2017

SYNCOM:The Exchange had sought clarification from Syncom Healthcare Limited with respect to announcement dated 13-Oct-2017, regarding " Syncom Healthcare Limited has informed the Exchange regarding 'MATERIAL EVENTS UNDER REGULATION 30 OF THE LISTING REGULATIONS '.". On basis of above the Company is required to clarify following: 1. Subsequently, the listed entity shall inform the stock exchange(s), the actual impact (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the key license/ approval.2. Period for w